RetaCalc
Protocol library
SingleInvestigationalEarly HumanModerate confidenceSourced

Kisspeptin

A reproductive neuropeptide studied in specialist fertility research. Molecule length, bolus versus infusion and ovarian context materially change the protocol.

Evidence context, not a personal protocol

Quantities below reproduce their stated source context—label, human study, laboratory work or educational guide. They do not assess suitability, product equivalence or individual risk.

Dosage and protocol evidence

Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.

Human Study
Women undergoing in vitro fertilisation

A single subcutaneous kisspeptin-54 bolus at 1.6, 3.2, 6.4 or 12.8 nmol/kg after follicle monitoring

The study used ultrasound-defined timing to trigger oocyte maturation within a full IVF protocol.

View source
Human Study
Healthy women in the early follicular phase

Eight-hour subcutaneous kisspeptin-54 infusion at 0.1, 0.3 or 1.0 nmol/kg/hour

This four-person physiology study used an infusion pump and serial hormone sampling.

View source

Evidence summary

A reproductive neuropeptide studied in specialist fertility research. Molecule length, bolus versus infusion and ovarian context materially change the protocol.

Protocol basis

The cited protocols are specialist reproductive studies with different molecular forms and delivery patterns. Those details are essential to interpreting any quantity.

What remains uncertain

There is no general-purpose schedule, and retail product identity may not match the kisspeptin form used in a cited trial.

Warnings and contraindications

Kisspeptin-10 and kisspeptin-54 are different research molecules.
Fertility studies require ultrasound, hormone monitoring and specialist timing.
A research schedule cannot be separated from ovarian stimulation and rescue procedures.